Best Buy Bones Inc. – FDA 483, May 3, 2024

Best Buy Bones Inc., a pet treat manufacturer in Mount Morris, MI, was cited for multiple deficiencies related to its hazard analysis and preventive controls during an FDA inspection. Observations included a lack of a written supply-chain program, failure to identify all foreseeable hazards, absence of written preventive control procedures, incomplete monitoring records, and inadequate implementation of preventive controls for biological pathogens. These issues indicate significant gaps in the firm's food safety management system.